BioBridgeXAll companies

Cerenome, Inc.

Medical device company · Houston, Texas, United States · Nasdaq: CNSY

Cerenome, Inc. is a medical device company headquartered in Houston, Texas, United States. Its shares trade on Nasdaq under the ticker CNSY. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $249,877 in total, most recently in 2007. It has reported private securities offerings to the US SEC, most recently $300,000 sold in a notice filed in 2020.

plustherapeutics.comProfile compiled from public records. Is this your company? Request a correction or update

Cerenome at a glance

Typemedical device company
HeadquartersHouston, Texas, United States
Stock listingNasdaq: CNSY
SEC industrySurgical & Medical Instruments & Apparatus
Employees (self-reported, 2007)17
SEC CIK1095981

What does Cerenome do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $249,877 in total (2007).

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $300,000 sold (2020).

Frequently asked questions about Cerenome

Where is Cerenome headquartered?

Cerenome, Inc. is headquartered in Houston, Texas, United States.

What does Cerenome do?

Cerenome, Inc. is a medical device company. Its SEC industry classification is Surgical & Medical Instruments & Apparatus.

Is Cerenome a public company?

Yes. Cerenome, Inc. trades on Nasdaq under the ticker CNSY.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-24. Data licences